Cohance Lifesciences consolidated net profit declines 46.50% in the September 2025 quarter
(13 Nov 2025)

Back
Net profit of Cohance Lifesciences declined 46.50% to Rs 74.08 crore in the quarter ended September 2025 as against Rs 138.47 crore during the previous quarter ended September 2024. Sales declined 7.98% to Rs 555.57 crore in the quarter ended September 2025 as against Rs 603.77 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales555.57603.77 -8
OPM %21.7734.01 -
PBDT127.79211.95 -40
PBT83.77174.16 -52
NP74.08138.47 -47

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew